• Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • Financial Information
      • SEC Filings
    • Stock
      • Stock Performance
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Management Team
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Contact Us
      • Email Alerts
Skip to main content
Mirum Pharmaceuticals Inc

Committee Composition

  • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • Financial Information
      • SEC Filings
    • Stock
      • Stock Performance
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Management Team
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Contact Us
      • Email Alerts

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Mirum Pharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Mirum Pharma to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*





Unsubscribe

Email Alert Sign Up Confirmation

Investor Contacts

Andrew McKibben

650-667-4085
ir@mirumpharma.com

Sam Martin
Argot Partners

212-600-1902
ir@mirumpharma.com

Media Contact

Erin Murphy

510-508-6521
media@mirumpharma.com


Quick Links

  • SEC Filings
  • Investor FAQs
  • Governance Documents
instagram linkedin twitter facebook Install Free Assistive Technology
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • CA TISCAD
Mirum Pharmaceuticals Inc
© Mirum Pharmaceuticals Inc. - All rights reserved
Powered By Q4 Inc. 5.103.0.4 (opens in new window)